<?xml version='1.0' encoding='utf-8'?>
<document id="31929946"><sentence text="Pharmacokinetics and enterohepatic circulation of jervine, an antitumor steroidal alkaloid from Veratrum nigrum in rats."><entity charOffset="82-90" id="DDI-PubMed.31929946.s1.e0" text="alkaloid" /></sentence><sentence text="Jervine, a novel steroidal alkaloid from Veratrum nigrum L"><entity charOffset="0-7" id="DDI-PubMed.31929946.s2.e0" text="Jervine" /><entity charOffset="27-35" id="DDI-PubMed.31929946.s2.e1" text="alkaloid" /><pair ddi="false" e1="DDI-PubMed.31929946.s2.e0" e2="DDI-PubMed.31929946.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31929946.s2.e0" e2="DDI-PubMed.31929946.s2.e1" /></sentence><sentence text=", exhibits both antitumor effect and potential toxicity" /><sentence text=" The aim of study was to characterize the pharmacokinetic behaviors and enterohepatic circulation of jervine in rats" /><sentence text=" A rapid and simple ultra-high performance liquid chromatography-tandem mass spectrometric method was developed and validated for quantification of jervine and alpinetin (internal standard) in rat plasma"><entity charOffset="160-169" id="DDI-PubMed.31929946.s5.e0" text="alpinetin" /></sentence><sentence text=" After extraction from rat plasma by a simple protein-precipitation method, the analyte was separated on a C18 column (2" /><sentence text="1 mm × 50 mm, 1" /><sentence text="7 μm) using water with 0" /><sentence text="1% formic acid and acetonitrile as the mobile phase delivered at a flow rate of 0"><entity charOffset="3-14" id="DDI-PubMed.31929946.s9.e0" text="formic acid" /><entity charOffset="19-31" id="DDI-PubMed.31929946.s9.e1" text="acetonitrile" /><pair ddi="false" e1="DDI-PubMed.31929946.s9.e0" e2="DDI-PubMed.31929946.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31929946.s9.e0" e2="DDI-PubMed.31929946.s9.e1" /></sentence><sentence text="4 mL/min" /><sentence text=" Jervine and alpinetin were determined in the positive mode with multiple reaction monitoring (MRM) of the ion transitions at m/z 426"><entity charOffset="1-8" id="DDI-PubMed.31929946.s11.e0" text="Jervine" /><entity charOffset="13-22" id="DDI-PubMed.31929946.s11.e1" text="alpinetin" /><pair ddi="false" e1="DDI-PubMed.31929946.s11.e0" e2="DDI-PubMed.31929946.s11.e0" /><pair ddi="false" e1="DDI-PubMed.31929946.s11.e0" e2="DDI-PubMed.31929946.s11.e1" /></sentence><sentence text="3 → 108" /><sentence text="8 and m/z 271" /><sentence text="0 → 166" /><sentence text="9, respectively" /><sentence text=" Molecular docking method was used to investigate the binding of jervine to p-glycoprotein and dehydroepiandrosterone sulfotransferase"><entity charOffset="95-117" id="DDI-PubMed.31929946.s16.e0" text="dehydroepiandrosterone" /></sentence><sentence text=" The method was well validated within acceptance limits including specificity, matrix effect, recovery, precision, accuracy, and stability, and was successfully applied to the pharmacokinetic study of jervine after oral and intravenous administration to rats" /><sentence text=" Jervine presented a small volume of distribution, fast absorption, high oral bioavailability, and enterohepatic circulation" /><sentence text=" The enterohepatic circulation was first observed in veratrum alkaloids, and was further investigated by molecular docking studies, which was related to the binding of jervine to p-glycoprotein and dehydroepiandrosterone sulfotransferase"><entity charOffset="62-71" id="DDI-PubMed.31929946.s19.e0" text="alkaloids" /><entity charOffset="198-220" id="DDI-PubMed.31929946.s19.e1" text="dehydroepiandrosterone" /><pair ddi="false" e1="DDI-PubMed.31929946.s19.e0" e2="DDI-PubMed.31929946.s19.e0" /><pair ddi="false" e1="DDI-PubMed.31929946.s19.e0" e2="DDI-PubMed.31929946.s19.e1" /></sentence><sentence text=" The pharmacokinetic properties and enterohepatic circulation of jervine in rats provided a significant basis for the drug-drug interaction and toxicity study in the future" /><sentence text="" /></document>